BWLSA
HTGM

Blue Water Life Science Advisors’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Blue Water Life Science Advisors’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,073
Closed -$841K – 27
2021
Q2 		$841K Sell
12,073
-343
-3% -$18.6K 0.32% 9
2021
Q1 		$375K Buy
+12,416
New +$942K 0.18% 21

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Blue Water Life Science Advisors's HTGM Position: Q3 2021 in Review

Blue Water Life Science Advisors sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2021, closing a stake of 12,073 shares — an estimated $841K sold.

Blue Water Life Science Advisors first reported a position in HTGM in Q1 2021 and held it in 2 quarters. The position peaked at $841K in Q2 2021. 23 funds tracked by Wall St. Rank hold HTGM as of Q3 2021.

  • Blue Water Life Science Advisors reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 12,073 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2021, an estimated $841K.
  • Blue Water Life Science Advisors first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Blue Water Life Science Advisors's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $841K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2021.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.